July 24, 2025 · Form 4 insider transaction
Reynolds Cameron John bought 200,000 shares of VOLITIONRX LTD at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4.
The reporting person received 200,000 restricted stock units under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of a closing stock price target above $2.50 per share of the Issuer's common stock for a minimum of thirty consecutive trading days prior to July 24, 2028, which date shall be no earlier than July 24, 2026, and also subject to time-based vesting in a single installment six months after the timely achievement of the target, if at all.